23rd Apr 2019

New Zealand Update: Patent fees on the increase, but are they Excess-ively complex?

Following our previous update in November (here), we now report on progress that has been made regarding upcoming changes to patent fees in New Zealand. While many of the fee...

Following our previous update in November (here), we now report on progress that has been made regarding upcoming changes to...

Read More

29th Nov 2018

New Zealand Update: Proposed Changes in Patent Legislation and Fees

In this article, we review some recent developments, including: - Upcoming examination request deadlines and a change in practice at the Intellectual Property Office of New Zealand (IPONZ); - Proposed increases...

In this article, we review some recent developments, including: - Upcoming examination request deadlines and a change in practice at...

Read More

27th Sep 2018

Clarification on Data Collection Requirements for Patent Term Extensions: Section 76A Repealed

Patentees applying for patent term extensions (PTE) in Australia may be familiar with section 76A of the Patents Act 1990, which required that the Department of Health be notified...

Patentees applying for patent term extensions (PTE) in Australia may be familiar with section 76A of the Patents Act...

Read More

22nd Jun 2018

First interlocutory injunction granted in Australia restraining the threatened launch of a biosimilar

On 12 June 2018, Justice Burley of the Federal Court of Australia granted the first interlocutory injunction to restrain the threatened launch of a biosimilar pharmaceutical product in Australia,...

On 12 June 2018, Justice Burley of the Federal Court of Australia granted the first interlocutory injunction to restrain...

Read More

31st Aug 2017

Commonwealth of Australia v Sanofi: Hearing of Commonwealth’s Claim Commences in Federal Court of Australia

A six-week hearing in the Federal Court of Australia commenced this week to decide whether the Commonwealth is entitled to damages related to generics being delayed from listing on...

A six-week hearing in the Federal Court of Australia commenced this week to decide whether the Commonwealth is entitled...

Read More

28th Aug 2017

A recipe for patent reform: Australian Government releases its response to Productivity Commission’s Final Report on IP Arrangements in Australia

Late last week, the Australian Government published its much-anticipated response to the Productivity Commission’s Inquiry into IP Arrangements in Australia. The response follows the Commission’s Final Report, which was...

Late last week, the Australian Government published its much-anticipated response to the Productivity Commission’s Inquiry into IP Arrangements in...

Read More

18th Apr 2017

Full Federal Court confirms that applying for PBS listing may not be an infringement

On appeal from Apotex Pty Ltd v Warner-Lambert LLC (No 3) FCA 94, which we recently reported on here, the Full Federal Court has confirmed in Warner-Lambert Company...

On appeal from Apotex Pty Ltd v Warner-Lambert LLC (No 3) FCA 94, which we recently reported on...

Read More

16th Feb 2017

Australia Update: When is applying for listing on the Pharmaceutical Benefits Scheme not an infringement?

In the most recent judgement in the Australian Lyrica® litigation Nicholas J has delivered an interesting decision regarding whether applying for Pharmaceutical Benefits Scheme (PBS) listing constitutes infringement of...

In the most recent judgement in the Australian Lyrica® litigation Nicholas J has delivered an interesting decision regarding whether...

Read More

22nd Dec 2016

Australian Government releases Productivity Commission’s final report on IP arrangements

In December 2016 the Australian Government released the Productivity Commission's final Report on Intellectual Property (IP) arrangements in Australia.

In December 2016 the Australian Government released the Productivity Commission's final Report on Intellectual Property (IP) arrangements in Australia.

Read More

1st Mar 2016

Second Medical Use Claims in Australia

The pharmaceutical industry is an important driver of patent activity. Amongst the protections sought are second medical uses, wherein a known substance is to be used in a novel...

The pharmaceutical industry is an important driver of patent activity. Amongst the protections sought are second medical uses, wherein...

Read More

6th Oct 2015

Trans-Pacific Partnership Agreement Announced

Last night, finalisation of the 12-country Trans-Pacific Partnership (TPP) Agreement between Australia, Brunei Darussalam, Canada, Chile, Japan, Malaysia, Mexico, New Zealand, Peru, Singapore, the US and Vietnam was announced...

Last night, finalisation of the 12-country Trans-Pacific Partnership (TPP) Agreement between Australia, Brunei Darussalam, Canada, Chile, Japan, Malaysia, Mexico,...

Read More

2nd Sep 2015

High Court Dismisses AstraZeneca Appeal

In our recent article of 26 June 2015 we reported on the High Court of Australia hearing on 13 and 14 May 2015 of the Appeal in the rosuvastatin...

In our recent article of 26 June 2015 we reported on the High Court of Australia hearing on 13...

Read More